{"id":"hec585","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding HEC585's specific molecular mechanism. As a phase 3 candidate from Sunshine Lake Pharma, it has progressed through early-stage development, but detailed mechanistic data has not been widely disclosed in accessible pharmaceutical databases or literature.","oneSentence":"HEC585 is an investigational therapeutic agent in phase 3 development by Sunshine Lake Pharma with an undisclosed mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:47:40.735Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07082842","phase":"PHASE3","title":"Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF","status":"NOT_YET_RECRUITING","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2025-10-09","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":472},{"nctId":"NCT05060822","phase":"PHASE2","title":"Phase ll Study of HEC585 in Patients With IPF","status":"UNKNOWN","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2021-06-30","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":270},{"nctId":"NCT05139719","phase":"PHASE2","title":"A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients","status":"RECRUITING","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2023-02-15","conditions":"Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)","enrollment":110},{"nctId":"NCT05468346","phase":"PHASE1","title":"Study on the Body Mass Balance and Biotransformation of [14C]-HEC585","status":"COMPLETED","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2022-07-26","conditions":"Healthy Volunteer","enrollment":6},{"nctId":"NCT04625361","phase":"PHASE1","title":"Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2021-01-20","conditions":"Parkinson Disease","enrollment":106},{"nctId":"NCT05383131","phase":"PHASE1","title":"To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers","status":"COMPLETED","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2021-06-23","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":33},{"nctId":"NCT04512170","phase":"PHASE1","title":"Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2020-07-13","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":72},{"nctId":"NCT03092102","phase":"PHASE1","title":"The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2017-05-20","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":136}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HEC585","genericName":"HEC585","companyName":"Sunshine Lake Pharma Co., Ltd.","companyId":"sunshine-lake-pharma-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}